63. 特発性血小板減少性紫斑病 ［臨床試験数：311，薬物数：185（DrugBank：39），標的遺伝子数：43，標的パスウェイ数：132］
Searched query = "Idiopathic thrombocytopenic purpura", "Primary immune thrombocytopenia"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
|1||ChiCTR2000030603||2020-05-01||2020-03-08||Clinical study on the safety and efficacy of short - course glucocorticoid treatment in patients with refractory glucocorticoid-dependent primary immune thrombocytopenia||Clinical study on the safety and efficacy of short - course glucocorticoid treatment in patients with refractory glucocorticoid-dependent primary immune thrombocytopenia||Primary Immune Thrombocytopenia||The short -course glucocorticoid group:treat with glucocorticoid;The eltrombopag group:treat with eltrombopag;The rituximab group:treat with rituximab;Splenectomy group:treat with splenectomy;The azathioprine group:treat with azathioprine;The cyclosporine group:treat with cyclosporine;||The Second Affiliated Hospital of Kunming Medical University||NULL||Pending||18||75||Both||The short -course glucocorticoid group:65;The eltrombopag group:65;The rituximab group:65;Splenectomy group:65;The azathioprine group:65;The cyclosporine group:65;||Phase 4||China|
|2||ChiCTR1900027753||2019-12-01||2019-11-25||Efficacy and safety of cyclosporine and azathioprine in patients with refractory ITP||Efficacy and safety of cyclosporine and azathioprine in patients with refractory ITP||Primary Immune Thrombocytopenia||Group 1:Using cyclosporine A for treatment;Group 2:Using azathioprine for treatment;Control group:Treatment with glucocorticoids;||the Second Affiliated Hospital of Kunming Medical University||NULL||Pending||18||75||Both||Group 1:30;Group 2:30;Control group:30;||N/A||China|
|3||ChiCTR-OON-17014165||2018-01-01||2017-12-27||A clinical trial to evaluate the efficacy and safety of corticosteroids combined with cyclosporin A in the treatment of primary immune thrombocytopenia||A clinical trial to evaluate the efficacy and safety of corticosteroids combined with cyclosporin A in the treatment of primary immune thrombocytopenia||Immune Thrombocytopenia||one:Corticosteroids;two:Corticosteroids combined with Cyclosporin A ;||Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology||NULL||Recruiting||18||65||Both||one:100;two:100;||China|
|September 2011||19/9/2011||Pharmacokinetic and Pharmacodynamic Study in Healthy Subjects Comparing the Interactions Between E5501 and Verapamil and Cyclosporine.||An Open-label, Single-sequence, Four-treatment Period Study to Evaluate Pharmacokinetic and Pharmacodynamic Interactions Between E5501 and Verapamil, and E5501 and Cyclosporine, Known P-glycoprotein Inhibitors in Healthy Subjects||Idiopathic Thrombocytopenic Purpura (ITP)||Drug: E5501||Eisai Inc.||NULL||Completed||18 Years||55 Years||Both||36||Phase 1||United States|